Federal Trade Commission v. Mylan Laboratories, Inc.

99 F. Supp. 2d 1, 1999 WL 1705505
District Court, District of Columbia·Decided December 14, 1999·No. 98-3114 (TFH), 98-3115(TFH)·Published·Cited by 31 cases

Opinion

OPINION

THOMAS F. HOGAN, District Judge.

The above-captioned cases are actions by the Federal Trade Commission (FTC) and thirty-three States against Mylan Laboratories and other drug companies for various federal and state law antitrust violations. On July 7, 1999, this Court issued a Memorandum Opinion granting in part and denying in part defendants’ motions to dismiss [1999-2 Trade Cases ¶ 72,573]. The Opinion addressed issues of federal law and the various antitrust and consumer protection laws of the plaintiff states. Sixteen of the plaintiff states have moved for reconsideration of the Court’s ruling in respect to various issues decided under their state laws. 1 Two of the states seeking reconsideration-Ohio and Kentucky-have also asked this Court to certify the questions of state law to their highest state courts. After careful consideration of plaintiffs’ motion and the opposition thereto, the motion will be granted in part and denied in part.

I. BACKGROUND

The plaintiff states request that this Court reconsider a number of its rulings in respect to the states’ antitrust and consumer protection laws. The states seeking reconsideration argue that: (1) the interpretation of the Supreme Court’s decision in Illinois Brick Co. v. Illinois, 431 U.S. 720, 97 S.Ct. 2061, 52 L.Ed.2d 707 (1977), relied on in the July 7, 1999 Memorandum Opinion, conflicts with the Supreme Court’s subsequent ruling in California v. ARC America Corp., 490 U.S. 93, 109 S.Ct. 1661, 104 L.Ed.2d 86 (1989); (2) the Court mistakenly dismissed various state claims for equitable monetary relief in light of the Court’s ruling on Idaho’s claims under the Idaho Consumer Protection Act (ICPA); and (3) the Court mistakenly dismissed various state damages claims on behalf of both direct and indirect purchasers. The Court will address these arguments generally, and then apply that discussion to the individual state statutes.

II. DISCUSSION

A. Standard of Review

Under Federal Rule of Civil Procedure 54(b), a party may seek to revise an order or other form of decision “at any time before the entry of judgment adjudicating all of the claims and the rights and liabilities of all of the parties.” Fed.R.Civ.P. 54(b). “Because federal courts have a strong interest in the finality of judgments, motions for reconsideration should be granted sparingly.” Continental Casualty Co. v. Diversified Indus., Inc., 884 F.Supp. 937, 943 (E.D.Pa.1995). Nevertheless, “[i]t is clear ... that there are circumstances when a motion to reconsider may perform a valuable function.” Above the Belt v. Mel Bohannan Roofing, Inc., 99 F.R.D. 99, 101 (E.D.Va.1983). In such circumstances, a Rule 54(b) motion can operate as the proper mechanism “for correcting errors and preventing injustice.” United States ex rel. Houck v. Folding Carton Admin. Committee, 121 F.R.D. 69, 70 (N.D.Ill.1988).

B. Substantive Arguments

1. Illinois Brick and ARC America

The plaintiff states seeking reconsideration argue that this Court adopted an overly expansive interpretation of the Supreme Court’s decision in Illinois Brick. The states argue that this Court held that Illinois Brick in effect pre-empted state laws addressing the rights of indirect purchasers, in violation of the principles set forth *4 by the Supreme Court in California v. ARC America Corp.

The states’ argument is based on a misunderstanding of both ARC America and this Court’s Memorandum Opinion. ARC America addressed the preemptive effect of Illinois Brick’s decision to deny standing to indirect purchasers under the Clayton Act. The issue was whether those states that had passed statutes expressly granting standing to indirect purchasers (so-called “Illinois Brick repealer statutes”) could enforce those statutes in light of the federal adoption of the indirect purchaser doctrine. See ARC America, 490 U.S. at 100, 109 S.Ct. 1661. The Supreme Court held that they could, as the decision in Illinois Brick was not intended to have a preemptive effect on the state’s ability to craft and enforce their own antitrust laws. Id. at 105-06, 109 S.Ct. 1661.

Contrary to plaintiffs’ argument, the ARC America Court did not hold that state courts were forbidden from relying on Illinois Brick as persuasive authority for how a state should interpret its antitrust regime. As noted by the Florida Court of Appeals:

[ARC America ] is not to say that the concerns raised in Hanover Shoe[, Inc. v. United Shoe Machinery Corp., 392 U.S. 481, 88 S.Ct. 2224, 20 L.Ed.2d 1281 (1968)] and Illinois Brick-the difficulties of tracing overcharges through a distribution chain, the possibility of multiple liability for defendants, and the prospects- of inconsistent or duplicate federal and state judgments-are not valid policy considerations under state antitrust or deceptive trade practice statutes. ARC America simply declines to impose on each state the federal legisla-five antitrust policy of deterring violations by simplifying antitrust litigation.

Mack v. Bristol-Myers Squibb, 673 So.2d 100, 107-08 (Fla.App.1996) review dism’d, 689 So.2d 1068 (Fla. Jan.31, 1997). Indeed, a number of courts have looked to Illinois Brick to determine the scope and structure of state antitrust laws. See, e.g., Boos v. Abbott Labs., 925 F.Supp. 49 (D.Mass.1996); Stifflear v. Bristol-Myers Squibb Co., 931 P.2d 471 (Colo.Ct.App.1996); Abbott Labs. v. Segura, 907 S.W.2d 503 (Tex.1995). The fact that this Court similarly sought guidance from Illinois Brick’s discussion of antitrust policy does not conflict with the Supreme Court’s ruling in ARC America. Thus, insofar as the states have asserted that this Court’s interpretation of Illinois Brick was improper, their motion is denied.

2. State Restitution Claims

A number of states ask this Court to reconsider its rulings disallowing state restitution claims.

Free access — add to your briefcase to read the full text and ask questions with AI

Federal Trade Commission v. Mylan Laboratories, Inc., 99 F. Supp. 2d 1, 1999 WL 1705505 (D.D.C. 1999).

99 F. Supp. 2d 1 (Federal Trade Commission v. Mylan Laboratories, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Connecticut v. Sandoz, Inc.
D. Connecticut, 2024
Smith v. GE Healthcare Inc
W.D. Louisiana, 2019
State v. Astra Zeneca AB
249 So. 3d 38 (Louisiana Court of Appeal, 2018)
Com. of PA Acting by AG Kathleen Kane v. Golden Gate National Senior Care LLC
158 A.3d 203 (Commonwealth Court of Pennsylvania, 2017)
Commonwealth of Kentucky v. Marathon Petroleum Co.
191 F. Supp. 3d 694 (W.D. Kentucky, 2016)
In re Processed Egg Products Antitrust Litigation
312 F.R.D. 124 (E.D. Pennsylvania, 2015)
In re Lidoderm Antitrust Litigation
103 F. Supp. 3d 1155 (N.D. California, 2015)
In re Niaspan Antitrust Litigation
42 F. Supp. 3d 735 (E.D. Pennsylvania, 2014)
New Cingular Wirelss v. Town of Stoddard, et
2012 DNH 046 (D. New Hampshire, 2012)
United States Ex Rel. Lisitza v. Johnson & Johnson
765 F. Supp. 2d 112 (D. Massachusetts, 2011)
In Re Flash Memory Antitrust Litigation
643 F. Supp. 2d 1133 (N.D. California, 2009)
In Re TFT-LCD (Flat Panel) Antitrust Litigation
586 F. Supp. 2d 1109 (N.D. California, 2008)
California v. Infineon Technologies AG
531 F. Supp. 2d 1124 (N.D. California, 2007)
In Re Dynamic Random Access Memory (DRAM) Antitrust Litigation
516 F. Supp. 2d 1072 (N.D. California, 2007)
Freeman Industries, LLC v. Eastman Chemical Co.
172 S.W.3d 512 (Tennessee Supreme Court, 2005)
State v. Weinschenk
2005 ME 28 (Supreme Judicial Court of Maine, 2005)